These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 1845228)

  • 21. Free radical pathology in schizophrenia: a review.
    Reddy RD; Yao JK
    Prostaglandins Leukot Essent Fatty Acids; 1996 Aug; 55(1-2):33-43. PubMed ID: 8888121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Free radical oxidative damage and Alzheimer's disease.
    Tuppo EE; Forman LJ
    J Am Osteopath Assoc; 2001 Dec; 101(12 Suppl Pt 1):S11-5. PubMed ID: 11794746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropsychiatric manifestations of typhoid fever in 959 patients.
    Osuntokun BO; Bademosi O; Ogunremi K; Wright SG
    Arch Neurol; 1972 Jul; 27(1):7-13. PubMed ID: 4340378
    [No Abstract]   [Full Text] [Related]  

  • 24. Mitochondrial importance in Alzheimer's, Huntington's and Parkinson's diseases.
    Correia SC; Santos RX; Perry G; Zhu X; Moreira PI; Smith MA
    Adv Exp Med Biol; 2012; 724():205-21. PubMed ID: 22411245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metal ions and oxidative protein modification in neurological disease.
    Sayre LM; Moreira PI; Smith MA; Perry G
    Ann Ist Super Sanita; 2005; 41(2):143-64. PubMed ID: 16244388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parkinson's disease, Huntington's disease and tardive dyskinesia. Neurochemical pathology and treatment.
    Tolosa ES
    Minn Med; 1979 Feb; 62(2):101-6. PubMed ID: 155195
    [No Abstract]   [Full Text] [Related]  

  • 27. Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases.
    Seeman P; Bzowej NH; Guan HC; Bergeron C; Reynolds GP; Bird ED; Riederer P; Jellinger K; Tourtellotte WW
    Neuropsychopharmacology; 1987 Dec; 1(1):5-15. PubMed ID: 2908095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Linking lipid peroxidation and neuropsychiatric disorders: focus on 4-hydroxy-2-nonenal.
    Romano A; Serviddio G; Calcagnini S; Villani R; Giudetti AM; Cassano T; Gaetani S
    Free Radic Biol Med; 2017 Oct; 111():281-293. PubMed ID: 28063940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Free radicals and neural cell damage].
    Ogawa N
    Rinsho Shinkeigaku; 1994 Dec; 34(12):1266-8. PubMed ID: 7774131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The endocrinology of extrapyramidal system disorders.
    Kirkpatrick B; Tamminga CA
    Neurol Clin; 1988 Feb; 6(1):159-72. PubMed ID: 2967909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down's syndrome and Parkinson's disease.
    Hestnes A; Daniel SE; Lees AJ; Brun A
    J Neurol Neurosurg Psychiatry; 1997 Mar; 62(3):289. PubMed ID: 9069490
    [No Abstract]   [Full Text] [Related]  

  • 32. Neuropsychiatric disorders in early untreated Parkinson's disease.
    Starkstein SE
    J Neurol Neurosurg Psychiatry; 2009 Aug; 80(8):830. PubMed ID: 19608781
    [No Abstract]   [Full Text] [Related]  

  • 33. Dietary alkyl thiol free radicals (RSS) can be as toxic as reactive oxygen species (ROS).
    Wiseman A
    Med Hypotheses; 2004; 63(4):667-70. PubMed ID: 15325013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clozapine therapy for Parkinson's disease and other movement disorders.
    Pfeiffer C; Wagner ML
    Am J Hosp Pharm; 1994 Dec; 51(24):3047-53. PubMed ID: 7856623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Electroconvulsive therapy in neurologic diseases].
    Folkerts H
    Nervenarzt; 1995 Apr; 66(4):241-51. PubMed ID: 7783810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pesticides and metals induced Parkinson's disease: involvement of free radicals and oxidative stress.
    Singh C; Ahmad I; Kumar A
    Cell Mol Biol (Noisy-le-grand); 2007 May; 53(5):19-28. PubMed ID: 17543230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The endocrinology of extrapyramidal system disorders.
    Kirkpatrick B; Tamminga CA
    Endocrinol Metab Clin North Am; 1988 Mar; 17(1):159-72. PubMed ID: 2967753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Redox processes in neurodegenerative disease involving reactive oxygen species.
    Kovacic P; Somanathan R
    Curr Neuropharmacol; 2012 Dec; 10(4):289-302. PubMed ID: 23730253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic neurological diseases: their societal burdens and potential solutions.
    Johnson RT; Price DL
    J Chronic Dis; 1980; 33(3):129-33. PubMed ID: 6444418
    [No Abstract]   [Full Text] [Related]  

  • 40. Free radicals: important cause of pathologies refer to ageing.
    Venarucci D; Venarucci V; Vallese A; Battilà L; Casado A; De la Torre R; Lopez Fernandez ME
    Panminerva Med; 1999 Dec; 41(4):335-9. PubMed ID: 10705716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.